Chemical modulation of the biological activity of reutericyclin: A membrane-active antibiotic from lactobacillus reuteri

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Cherian, Philip T ^a   Wu, Xiaoqian ^b   Maddox, Marcus M ^a   Singh, Aman P ^a,c   Lee, Richard E ^a   Hurdle, Julian G ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG DERIVATIVE; REUTERICYCLIN; TENUAZONIC ACID;

ANIMAL; ARTICLE; CHEMISTRY; CHLOROCEBUS AETHIOPS; DRUG EFFECT; GRAM POSITIVE BACTERIUM; HUMAN; LACTOBACILLUS REUTERI; MEMBRANE; STRUCTURE ACTIVITY RELATION; VERO CELL LINE;

ANIMALS; ANTI-BACTERIAL AGENTS; CERCOPITHECUS AETHIOPS; GRAM-POSITIVE BACTERIA; HUMANS; LACTOBACILLUS REUTERI; MEMBRANES; STRUCTURE-ACTIVITY RELATIONSHIP; TENUAZONIC ACID; VERO CELLS;

EID: 84898780725     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04721     Document Type: Article

References (30)

1. Theuretzbacher, U. Global antibacterial resistance: The never-ending story. J. Global Antibiot. Resist. 1, 63-69 (2013).
2. Bush, K. et al. Tackling antibiotic resistance. Nat. Rev. Microbiol. 9, 894-896 (2011).
3. Boucher, H. W. et al. 10 x '20 Progress-development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 56, 1685-1694 (2013).
4. Hurdle, J. G., O'Neill, A. J., Chopra, I. & Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9, 62-75 (2011).
5. Zhu, X. et al. Design of imperfectly amphipathic alpha-helical antimicrobial peptides with enhanced cell selectivity. Acta Biomater. 10, 244-257 (2014).
6. Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37-51 (2012).
7. Holtzel, A., Ganzle, M. G., Nicholson, G. J., Hammes, W. P. & Jung, G. The first low molecular weight antibiotic from lactic acid bacteria: reutericyclin, a new tetramic acid. Angew. Chem. Int. Edit. 39, 2766-2768 (2000). (Pubitemid 30629213)
8. Ganzle, M. G., Holtzel, A.,Walter, J., Jung, G. & Hammes, W. P. Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl. Environ. Microbiol. 66, 4325-4333 (2000).
9. Hurdle, J. G.,Heathcott, A., Yang, L., Yan, B. R. E. Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations. J. Antimicrob. Chemother. 66, 1773-1776 (2011).
10. Hurdle, J. G., Yendapally, R., Sun, D. & Lee, R. E. Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections. Antimicrob. Agents Chemother. 53, 4028-4031 (2009).
11. Ganzle, M. G. & Vogel, R. F. Studies on the mode of action of reutericyclin. Appl. Environ. Microbiol. 69, 1305-1307 (2003). (Pubitemid 36204868)
12. Kaneda, T. Iso-and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. Microbiol. Rev. 55, 288-302 (1991). (Pubitemid 21895155)
13. Yendapally, R., Hurdle, J. G., Carson, E. I., Lee, R. B. & Lee, R. E. N-substituted 3-acetyltetramic acid derivatives as antibacterial agents. J. Med. Chem. 51, 1487-1491 (2008). (Pubitemid 351480411)
14. Schobert, R., Dietrich,M., Mullen, G. & Urbina-Gonzalez, J.-M. Phosphorus ylide based functionalizations of tetronic and tetramic acids. Synthesis 3902-3914 (2006). (Pubitemid 44870893)
15. Abe, M., Imai, T., Ishii, N. & Usui, M. Synthesis of quinolactacide via an acyl migration reaction and dehydrogenation with manganese dioxide, and its insecticidal activities. Biosci. Biotechnol. Biochem. 70, 303-306 (2006). (Pubitemid 43150997)
16. Stickings, C. E. Studies in the biochemistry of micro-organisms. 106. Metabolites of Alternaria tenuis auct.: the structure of tenuazonic acid. Biochem. J. 72, 332-340 (1959).
17. Royles, B. J. L. Naturally-occurring tetramic acids-structure, isolation, and synthesis. Chem. Rev. 95, 1981-2001 (1995).
18. Piddock, L. J. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4, 629-636 (2006). (Pubitemid 44317025)
19. Wu, X. & Hurdle, J. G. Screening for a diamond in the rough. Chem. Biol. 20, 1091-1092 (2013).
20. Novo, D., Perlmutter, N. G., Hunt, R. H. & Shapiro, H. M. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35, 55-63 (1999). (Pubitemid 29031192)
21. Novo, D. J., Perlmutter, N. G., Hunt, R. H. & Shapiro, H.M. Multiparameter flow cytometric analysis of antibiotic effects on membrane potential, membrane permeability, and bacterial counts of Staphylococcus aureus and Micrococcus luteus. Antimicrob. Agents Chemother. 44, 827-834 (2000). (Pubitemid 30165256)
22. Shapiro, H. M. Membrane potential estimation by flow cytometry. Methods 21, 271-279 (2000). (Pubitemid 32896751)
23. Peetla, C., Stine, A. & Labhasetwar, V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol. Pharm. 6, 1264-1276 (2009).
24. Takahashi, D., Shukla, S. K., Prakash, O. & Zhang, G. Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie 92, 1236-1241 (2010).
25. Farha, M. A., Verschoor, C. P., Bowdish, D. & Brown, E. D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chem. Biol. 20, 1168-1178 (2013).
26. Wu, X. et al. Prospects for flavonoid and related phytochemicals as natureinspired treatments for Clostridium difficile infection. J. Appl. Microbiol. 116, 23-31 (2014).
27. Rakesh et al. Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties. Bioorg. Med. Chem. 20 (2012).
28. Silverman, J. A., Perlmutter, N. G. & Shapiro, H. M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 2538-2544 (2003). (Pubitemid 36919456)
29. Oliva, B. et al. Biological properties of novel antistaphylococcal quinoline-indole agents. Antimicrob. Agents Chemother. 47, 458-466 (2003). (Pubitemid 36158068)
30. Sun, D. et al. Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead. ChemMedChem 7, 1541-1545 (2012).